Cargando…
Sustained immunotolerance in multiple sclerosis after stem cell transplant
OBJECTIVE: Autologous haematopoietic stem cell transplantation (AHSCT) has the potential to induce sustained periods of disease remission in multiple sclerosis (MS), which is an inflammatory disease of the central nervous system (CNS) characterised by demyelination and axonal degeneration. However,...
Autores principales: | Visweswaran, Malini, Hendrawan, Kevin, Massey, Jennifer C., Khoo, Melissa L., Ford, Carole D., Zaunders, John J., Withers, Barbara, Sutton, Ian J., Ma, David D. F., Moore, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862434/ https://www.ncbi.nlm.nih.gov/pubmed/35106961 http://dx.doi.org/10.1002/acn3.51510 |
Ejemplares similares
-
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation
por: Hendrawan, Kevin, et al.
Publicado: (2022) -
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018) -
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis
por: Massey, Jennifer, et al.
Publicado: (2022) -
A Triple-Transgenic Immunotolerant Mouse Model
por: Brenden, Nina, et al.
Publicado: (2013) -
Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
por: Faiella, Whitney, et al.
Publicado: (2016)